Notice of Closed Meeting, 15034 [2023-04919]
Download as PDF
<![CDATA[
15034
Federal Register / Vol. 88, No. 47 / Friday, March 10, 2023 / Notices
iterations of the SNHGQ have been
instrumental in the successful
investigation of these outbreaks. The
questionnaire has allowed investigators
to more efficiently and effectively
interview ill persons as they are
identified. Because these exposures are
captured in a common, standard format,
we have been able to share and analyze
data rapidly across jurisdictional lines.
Faster interview response and analysis
times have allowed for more rapid
epidemiologic investigation and quicker
regulatory action, thus helping to
prevent thousands of additional
illnesses from occurring and spurring
industry to adopt and implement new
food safety measures in an effort to
prevent future outbreaks.
CDC requests OMB approval for an
estimated 3,000 annualized burden
hours (approximately 4,000 individuals
identified during the hypothesisgenerating phase of outbreak
investigations with 45 minutes/
response). There are no costs to
respondents other than their time to
participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
(in hours)
Form name
Ill individuals identified as part of an
outbreak investigation.
Standardized National Hypothesis
Generating Questionnaire.
4,000
1
45/60
3,000
Total ...........................................
..........................................................
........................
........................
........................
3,000
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–04971 Filed 3–9–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondents
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
CE23–005, Panel A, Research Grants to
Inform Firearm-Related Violence and
Injury Prevention Strategies (R01).
Dates: April 17–18, 2023.
Times: 8:30 a.m.–5 p.m., EDT.
Place: Crowne Plaza Atlanta
Perimeter at Ravinia, 4355 Ashford
VerDate Sep<11>2014
17:45 Mar 09, 2023
Jkt 259001
Dunwoody Road NE, Atlanta, Georgia
30346.
Agenda: To review and evaluate grant
applications.
FOR FURTHER INFORMATION CONTACT:
Mikel Walters, Ph.D., Scientific Review
Officer, National Center for Injury
Prevention and Control, CDC, 4770
Buford Highway NE, Mailstop S106–9,
Atlanta, Georgia 30341; Telephone:
(404) 639–0913; Email: MWalters@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–04919 Filed 3–9–23; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
Frm 00065
Fmt 4703
Dan
Hartley, Ed.D., Scientific Review
Officer, Office of Extramural Programs,
National Institute for Occupational
Safety and Health, CDC, 1095
Willowdale Road, Morgantown, West
Virginia 26505; Telephone: (304) 285–
5812; Email: DHartley@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
FOR FURTHER INFORMATION CONTACT:
BILLING CODE 4163–18–P
PO 00000
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel;
(SEP)—RFA–OH–22–005, Commercial
Fishing Occupational Safety Research
Cooperative Agreement; and RFA–OH–
22–006, Commercial Fishing
Occupational Safety Training Project
Grants.
Date: May 17, 2023.
Time: 1 p.m.–5 p.m., EDT.
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant
applications.
Sfmt 4703
E:\FR\FM\10MRN1.SGM
10MRN1
]]>Agencies
[Federal Register Volume 88, Number 47 (Friday, March 10, 2023)]
[Notices]
[Page 15034]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04919]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--CE23-005, Panel A, Research
Grants to Inform Firearm-Related Violence and Injury Prevention
Strategies (R01).
Dates: April 17-18, 2023.
Times: 8:30 a.m.-5 p.m., EDT.
Place: Crowne Plaza Atlanta Perimeter at Ravinia, 4355 Ashford
Dunwoody Road NE, Atlanta, Georgia 30346.
Agenda: To review and evaluate grant applications.
FOR FURTHER INFORMATION CONTACT: Mikel Walters, Ph.D., Scientific
Review Officer, National Center for Injury Prevention and Control, CDC,
4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341;
Telephone: (404) 639-0913; Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-04919 Filed 3-9-23; 8:45 am]
BILLING CODE 4163-18-P
